SR ONE CAPITAL MANAGEMENT, LLC, Ten Percent Owner at Arcellx Inc, holds 4.91M shares in Zenas BioPharma, Inc. (Ticker: ZBIO), holds 6.21M shares in eFFECTOR Therapeutics (Ticker: EFTR), holds 4.49M shares in Arcellx Inc (Ticker: ACLX).
SR ONE CAPITAL MANAGEMENT, LLC insider profile FAQ
What is the percentage of profitable transactions made by SR ONE CAPITAL MANAGEMENT, LLC?
The percentage of profitable transactions made by SR ONE CAPITAL MANAGEMENT, LLC is 67%.
What is the average return per transaction made by SR ONE CAPITAL MANAGEMENT, LLC?
The average return per transaction made by SR ONE CAPITAL MANAGEMENT, LLC is 53.50%.
What stocks does SR ONE CAPITAL MANAGEMENT, LLC hold?
SR ONE CAPITAL MANAGEMENT, LLC holds: ACLX, EFTR, ZBIO stocks.
What was SR ONE CAPITAL MANAGEMENT, LLC’s latest transaction?
SR ONE CAPITAL MANAGEMENT, LLC latest transaction was an Uninformative Buy of ―.
What was SR ONE CAPITAL MANAGEMENT, LLC's most profitable transaction?
SR ONE CAPITAL MANAGEMENT, LLC’s most profitable transaction was an Informative Sell of EFTR stock on November 29, 2023. The return on the trade was 99.60%.
What is SR ONE CAPITAL MANAGEMENT, LLC's role in Arcellx Inc?
SR ONE CAPITAL MANAGEMENT, LLC's role in Arcellx Inc is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.